G-protein coupled glycoprotein hormone receptor aomf05
CA 2304986 A1 · Owner: O'Neill, Gary P. · Inventors: O'Neill, Gary P.; Mcdonald, Terrence P.; Abramovitz, Mark
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
This invention provides a novel G-protein coupled glycoprotein hormone receptor AOMF05, mutant and polymorphic forms of the receptor nucleic acids , encoding the same, expression vectors including the nucleic acids host cells , transformed with nucleic acids transgenic knockout animals lacking the receptor and transgenic animals expressing a non-native receptor gene antibodies against the receptor and polypeptides thereof and assays for modulators, agonists and antagonists of the receptor. The receptor proteins and polypeptides, nucleic acids, cells animals and assays of this invention , are useful in drug screening and development diagnosis and therapeutic , applications.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed September 24, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 24, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 24, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.